Prasugrel or clopidogrel in patients with acute coronary syndromes at high thrombotic risk: results from the PROMETHEUS study
28 August 2021 (20:33 - 20:42)
Organised by:
About the speaker

Clinical Institute Humanitas IRCCS, Rozzano (Italy)
3 More presentations in this session

Doctor N. Patel (Winston-Salem, US)

Doctor A. Elkaryoni (Providence, US)
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
28 August 2021
20:33 CET
